Jenner Institute tests malaria vaccine in Phase 1 trial

Scientists at the University of Oxford’s Jenner Institute have started a Phase 1 trial for a new candidate vaccine against malaria, which is designed to stimulate an immune response to the malaria parasite by using a genetically modified chimpanzee adenovirus.

Location